News & Updates

Show Multimedia Only

Novel extended-release tablet superior to febuxostat at reducing SUA levels

03 Jul 2026 by

An extended-release formulation, HR091506, performs better than febuxostat immediate release in lowering urate levels in patients with gout and hyperuricaemia, as shown in a phase III trial.

Novel extended-release tablet superior to febuxostat at reducing SUA levels

03 Jul 2026

Dostarlimab plus chemo prolongs survival in advanced dMMR/MSI-H endometrial cancer

02 Jul 2026 by

Treatment with dostarlimab combined with carboplatin and paclitaxel (CP) confers sustained long-term progression-free survival (PFS) and overall survival (OS) benefits on patients with primary advanced or recurrent deficient mismatch repair and microsatellite instability-high (dMMR/MSI-H) endometrial cancer, as shown by the results of the phase III RUBY trial.

Dostarlimab plus chemo prolongs survival in advanced dMMR/MSI-H endometrial cancer

02 Jul 2026

Gout predisposes AF patients to ischaemic stroke

30 Jun 2026 by

Gout may increase susceptibility of atrial fibrillation (AF) patients to ischaemic stroke, according to new research.

Gout predisposes AF patients to ischaemic stroke

30 Jun 2026

Imaging helps refine diagnosis and management in PsA

30 Jun 2026 by

Imaging complements clinical judgement in psoriatic arthritis (PsA) diagnosis and management, helping guide treatment to achieve remission or minimize disease progression, according to Professor Mikkel Østergaard of the University of Copenhagen, Denmark, who spoke at AIM 2026.

Imaging helps refine diagnosis and management in PsA

30 Jun 2026

Inflammatory arthritis patients with overweight, obesity at high risk of COVID-19

29 Jun 2026 by

Among patients with inflammatory arthritis receiving biologic or targeted synthetic disease-modifying anti-rheumatic drugs, those with overweight or obesity face an increased risk of COVID-19 infection, according to a study from Singapore.

Inflammatory arthritis patients with overweight, obesity at high risk of COVID-19

29 Jun 2026

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

28 Jun 2026

Treatment with oral glucocorticoids may contribute to elevated risks of adverse psychiatric outcomes, including the onset and relapse of common psychiatric disorders, as shown in a population-based cohort study.

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

28 Jun 2026

Psoriatic arthritis disease activity worsens during perimenopause

28 Jun 2026 by

Women with psoriatic arthritis (PsA) appear to experience increased disease activity, measured either objectively or subjectively, during the perimenopause stage, as shown in a study.

Psoriatic arthritis disease activity worsens during perimenopause

28 Jun 2026

Baricitinib a promising steroid-sparing option in early polymyalgia rheumatica

26 Jun 2026 by

The oral Janus kinase (JAK) inhibitor baricitinib has demonstrated efficacy in inducing and maintaining glucocorticoid-free remission in patients with early polymyalgia rheumatica, according to the phase 3 JAK-Spare trial.

Baricitinib a promising steroid-sparing option in early polymyalgia rheumatica

26 Jun 2026

Secukinumab improves outcomes in Chinese children with enthesitis-related arthritis

24 Jun 2026 by

Treatment with secukinumab helps reduce symptoms and disease activity in Chinese children with enthesitis-related arthritis, as shown in a retrospective study.

Secukinumab improves outcomes in Chinese children with enthesitis-related arthritis

24 Jun 2026

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

20 Jun 2026

The use of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) among adults with obesity and concomitant autoimmune diseases appears to lower the incidence of thromboembolic events, emergency department visits, and mortality, according to a study.

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

20 Jun 2026

News & Updates

Showing Rheumatology articles

Showing

Specialty:

Novel extended-release tablet superior to febuxostat at reducing SUA levels

Novel extended-release tablet superior to febuxostat at reducing SUA levels

Dostarlimab plus chemo prolongs survival in advanced dMMR/MSI-H endometrial cancer

Dostarlimab plus chemo prolongs survival in advanced dMMR/MSI-H endometrial cancer

Gout predisposes AF patients to ischaemic stroke

Gout predisposes AF patients to ischaemic stroke

Imaging helps refine diagnosis and management in PsA

Imaging helps refine diagnosis and management in PsA

Inflammatory arthritis patients with overweight, obesity at high risk of COVID-19

Inflammatory arthritis patients with overweight, obesity at high risk of COVID-19

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

Psoriatic arthritis disease activity worsens during perimenopause

Psoriatic arthritis disease activity worsens during perimenopause

Baricitinib a promising steroid-sparing option in early polymyalgia rheumatica

Baricitinib a promising steroid-sparing option in early polymyalgia rheumatica

Secukinumab improves outcomes in Chinese children with enthesitis-related arthritis

Secukinumab improves outcomes in Chinese children with enthesitis-related arthritis

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

GLP‐1RA offers cardiovascular, survival benefits in high-risk population